![Craig Eric Schneier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Craig Eric Schneier
Nessuna posizione attualmente
Storia della carriera di Craig Eric Schneier
Precedenti posizioni note di Craig Eric Schneier
Società | Posizione | Inizio | Fine |
---|---|---|---|
BIOGEN INC. | Ufficiale delle Risorse Umane | 18/03/2011 | 18/03/2011 |
Public Communications Contact | 18/03/2011 | 18/03/2011 | |
Biogen MA, Inc.
![]() Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Ufficiale delle Risorse Umane | 01/01/2001 | 01/11/2003 |
Biogen Idec New Ventures, Inc.
![]() Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Ufficiale delle Risorse Umane | 14/12/2010 | - |
Corporate Officer/Principal | 01/01/2001 | 14/12/2010 | |
Vendite & Marketing | 14/12/2010 | - |
Formazione di Craig Eric Schneier
The University of Colorado | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Human Resources Officer | 3 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIOGEN INC. | Health Technology |
Aziende private | 2 |
---|---|
Biogen MA, Inc.
![]() Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Biogen Idec New Ventures, Inc.
![]() Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
- Borsa valori
- Insiders
- Craig Eric Schneier
- Esperienza